Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 1487.5 | 72 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 1592.0 | 72 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 376.5 | 68 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 222.0 | 60 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 706.0 | 63 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 771.0 | 60 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 56.0 | 64 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 57.0 | 83 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 39.0 | 63 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 41.0 | 91 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 46.0 | 59 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 43.0 | 85 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 39.0 | 75 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 55.0 | 57 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 79.0 | 82 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | G-CSF | 77.0 | 58 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 51.0 | 81 | |
N2759 | TNF-a | 100 | ng/mL | 3 | G-CSF | 64.0 | 68 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 61.5 | 74 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | G-CSF | 65.5 | 56 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | G-CSF | 73.0 | 81 | |
N2586 | TNF-a | 100 | ng/mL | 3 | G-CSF | 72.0 | 77 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 17.0 | 67 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | G-CSF | 16.5 | 84 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 16.0 | 58 |